Covered recipient · General Payments record
MARK A WHITE
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2024
$5,315.93
- Reported across 371 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $525.15 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $301.83 | 24 |
| GlaxoSmithKline, LLC. | $58.45 | 4 |
| Lundbeck LLC | $45.65 | 2 |
| Phathom Pharmaceuticals, Inc. | $44.55 | 2 |
| Astellas Pharma US Inc | $21.59 | 1 |
| Exact Sciences Corporation | $21.11 | 1 |
| Alexion Pharmaceuticals, Inc. | $16.83 | 1 |
| Lilly USA, LLC | $15.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.61 | 01/09/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106332071 | CMS |
| ABBVIE INC. | $32.89 | 01/09/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106332073 | CMS |
| ABBVIE INC. | $14.38 | 01/16/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106332075 | CMS |
| ABBVIE INC. | $5.66 | 01/23/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106332077 | CMS |
| ABBVIE INC. | $21.80 | 01/30/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106332079 | CMS |
| ABBVIE INC. | $5.60 | 01/30/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106332081 | CMS |
| ABBVIE INC. | $29.55 | 01/30/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106332083 | CMS |
| ABBVIE INC. | $10.21 | 02/06/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106332085 | CMS |
| ABBVIE INC. | $15.19 | 02/20/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106332087 | CMS |
| ABBVIE INC. | $8.56 | 02/26/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106332089 | CMS |
| ABBVIE INC. | $21.70 | 02/28/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106332091 | CMS |
| ABBVIE INC. | $5.73 | 03/06/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106332093 | CMS |
| ABBVIE INC. | $5.12 | 03/12/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106332095 | CMS |
| ABBVIE INC. | $9.60 | 03/19/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106332097 | CMS |
| ABBVIE INC. | $7.77 | 03/25/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106332099 | CMS |
| ABBVIE INC. | $19.28 | 03/26/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106332101 | CMS |
| ABBVIE INC. | $8.66 | 04/04/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106332103 | CMS |
| ABBVIE INC. | $5.39 | 04/11/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106332105 | CMS |
| ABBVIE INC. | $7.17 | 04/24/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106332107 | CMS |
| ABBVIE INC. | $18.17 | 04/25/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106332109 | CMS |
| ABBVIE INC. | $6.72 | 05/06/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106332111 | CMS |
| ABBVIE INC. | $9.49 | 05/07/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106332113 | CMS |
| ABBVIE INC. | $9.48 | 05/14/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106332115 | CMS |
| ABBVIE INC. | $6.10 | 05/16/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106332117 | CMS |
| Alexion Pharmaceuticals, Inc. | $16.83 | 01/04/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1093896561 | CMS |
| Astellas Pharma US Inc | $21.59 | 05/08/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1139333332 | CMS |
| Exact Sciences Corporation | $21.11 | 03/13/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1114948646 | CMS |
| GlaxoSmithKline, LLC. | $14.03 | 01/18/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1116472449 | CMS |
| GlaxoSmithKline, LLC. | $13.42 | 02/20/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1116633351 | CMS |
| GlaxoSmithKline, LLC. | $15.50 | 03/14/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1116493830 | CMS |
| GlaxoSmithKline, LLC. | $15.50 | 05/09/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1116438313 | CMS |
| Lilly USA, LLC | $15.14 | 06/13/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1135115343 | CMS |
| Lundbeck LLC | $26.10 | 02/15/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1145980897 | CMS |
| Lundbeck LLC | $19.55 | 05/14/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1145980899 | CMS |
| Phathom Pharmaceuticals, Inc. | $24.55 | 03/12/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1151138837 | CMS |
| Phathom Pharmaceuticals, Inc. | $20.00 | 04/30/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1151138839 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.